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Objective. To examine the endocrine response to a bout of heavy resistance exercise following acute 𝛽-hydroxy-𝛽-methylbutyrate
free acid (HMB-FA) ingestion. Design. Twenty resistance trained men were randomized and consumed either 1 g of HMB-FA
(BetaTor) or placebo (PL) 30 min prior to performing an acute heavy resistance exercise protocol. Blood was obtained before (PRE),
immediately after (IP), and 30 min after exercise (30P). Circulating concentrations of testosterone, growth hormone (GH), insulinlike growth factor (IGF-1), and insulin were assayed. Data were analyzed with a repeated measures ANOVA and area under the
curve (AUC) was analyzed by the trapezoidal rule. Results. The resistance exercise protocol resulted in significant elevations from
PRE in testosterone (𝑃 < 0.01), GH (𝑃 < 0.01), and insulin (𝑃 = 0.05) at IP, with GH (𝑃 < 0.01) and insulin (𝑃 < 0.01) remaining
elevated at 30P. A significant interaction was noted between groups in the plasma GH response at IP, which was significantly higher
following HMB-FA compared to PL (𝑃 < 0.01). AUC analysis revealed an elevated GH and IGF-1 response in the HMB-FA group
compared to PL. Conclusion. HMB-FA prior to resistance exercise augments the GH response to high volume resistance exercise
compared to PL. These findings provide further support for the potential anabolic benefits associated with HMB supplementation.

1. Introduction
𝛽-Hydroxy-𝛽-methylbutyrate (HMB), a leucine derived
metabolite, has been demonstrated to augment strength
and lean muscle gains when supplemented in conjunction
with resistance training [1–4]. Recently, an 18% increase in
strength gain was demonstrated following 12 weeks of HMB
ingestion compared to placebo in experienced resistance
trained men [1]. However, earlier studies of HMB were not
consistent in demonstrating the efficacy of supplementation
in regard to performance improvements [2, 5–7]. Many of
the earlier studies used HMB formulated as a calcium salt
(HMB-Ca); however, a new free acid form of HMB (HMBFA) has been shown to yield higher plasma concentrations
in a shorter amount of time compared to the calcium salt
form [8]. The greater bioavailability of HMB-FA may provide
greater benefits regarding its efficacy as a nutrient supplement
used to enhance training adaptations.

While HMB has displayed robust anabolic/anticatabolic
properties, the underlying mechanisms regarding its efficacy
are not completely understood [9, 10]. HMB is known to
increase muscle protein synthesis through mTOR signaling
pathways while concurrently reducing proteolytic processes
[10–13]. Furthermore, evidence also exists demonstrating
HMB’s ability to modulate specific cytokines and immune
cells responsible for muscle tissue repair [14–16].
While several studies have observed an upregulation of
certain target proteins in the mTOR pathway [17, 18], less
is known about upstream components of the insulin-like
growth factor-1 (IGF-1) dependent pathway [19]. GerlingerRomero and colleagues [19] observed increased growth
hormone (GH) and hepatic IGF-1 expression, which corresponded to increased serum concentrations as a result of four
weeks of HMB administration in male rats, suggesting that
the effects of HMB may be mediated via IGF-1 activation of
the mTOR cascade. While chronic HMB-Ca supplementation
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in elite teen athletes did not alter the GH/IGF-1 axis [5],
to the best of our knowledge no studies are known that
have investigated the effects of HMB-FA on the acute hormonal response in trained humans, which may result in
proanabolic downstream effectors. Therefore, the purpose
of the present study was to investigate the effect of acute
HMB-FA ingestion on circulating concentrations of anabolic
hormones following a heavy resistance exercise protocol in
experienced, resistance trained men. We hypothesize that
HMB-FA administration will augment the anabolic hormone
response from a bout of resistance exercise resulting in
increased activity of the GH/IGF-1 axis.

2. Methods
2.1. Participants. Twenty resistance trained men (22.3 ± 2.4 y,
1.8 ± 0.1 m, and 7.3 ± 8.3 kg) volunteered to participate in this
study. Participants were randomly separated into one of two
groups: ingestion of HMB free acid (HMB-FA; 𝑛 = 10) or
ingestion of placebo (PL; 𝑛 = 10). Following an explanation
of all procedures, risks, and benefits, each participant gave
his informed consent prior to participation in this study.
The institutional review board for the protection of human
subjects of the university approved the research protocol. For
inclusion in this study, participants were required to have a
minimum of one year of resistance training experience, particularly in the squat exercise. Participants were not permitted
to use any additional nutritional supplements or medications
while enrolled in this study. Screening for nutritional and
hormonal supplements was accomplished via a health history
questionnaire completed during participant recruitment.
2.2. Study Protocol. The investigation utilized a placebocontrolled, double-blind, randomized design. Participants
reported to the laboratory on two occasions. On the first
visit (T1), participants were tested for their one-repetition
maximum (1-RM) on the barbell back squat, dead lift, and
barbell split squat exercises. Participants were instructed to
refrain from any form of exercise for a minimum of 72 hours
prior to the resistance training bout (T2). On T2, participants
completed a hypertrophy style lower-body resistance exercise
session, which consisted of four sets of the barbell back squat,
dead lift, and barbell split squat exercises. The barbell back
squat exercise was performed with 80% of the participant’s
1-RM and the dead lift and barbell split squat exercises were
performed with 70% of the participant’s 1-RM. Rest intervals
were set at 90 s between each set and between exercises.
Participants were encouraged to perform as many repetitions
as possible up to 10 repetitions for each set. The duration of
the acute exercise protocol was 45 minutes and total training
volume, calculated as repetitions × load, was recorded for
further analysis.
2.3. HMB Free Acid Supplementation. The HMB-FA supplement consisted of one gram of 𝛽-hydroxy-𝛽-methylbutyrate
in the free acid form (BetaTor, Metabolic Technologies
Inc., Ames, IA), reverse osmosis water, debittering agent,
flavor, stevia extract, and potassium carbonate. Each serving
of placebo contained one gram of polydextrose and was
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identical to the HMB-FA supplement in appearance and taste.
The HMB-FA and PL treatments were produced and supplied
by Metabolic Technologies Inc. (Ames, IA). One serving
of HMB-FA or PL was consumed 30 minutes prior to the
exercise session. All HMB-FA and PL ingestion took place in
the Human Performance Lab and was witnessed by one of the
investigators.
2.4. Anthropometric Measurements. Prior to maximal
strength testing, anthropometric measurements, including
height, body mass, and body fat percentage, were conducted.
Body mass (±0.1 kg) and height (±0.1 cm) were measured
using a Health-o-meter Professional (Patient Weighing
Scale, Model 500 KL, Pelstar, Alsip, IL, USA). All body
composition measures were performed using standardized
procedures previously described for collecting skinfold
measurement from the triceps, suprailiac, abdomen, and
thigh [20] and previously published formulas for calculating
body fat percentage [21]. All skinfold measurements were
performed by the same researcher using the same skinfold
caliper (Caliper-Skinfold-Baseline, Model #MDSP121110,
Medline, Mundelein, IL, USA).
2.5. Blood Measurements. During the T2 experimental session, blood samples were obtained before exercise (PRE),
immediately after exercise (IP), and 30 min after exercise
(30P). All blood samples were obtained using a 20-gauge
Teflon cannula placed in a superficial forearm vein using
a three-way stopcock with a male luer lock adapter. The
cannula was maintained patent using an isotonic saline
solution. PRE blood samples were drawn following a 15 min
equilibration period prior to exercise. All IP blood samples
were taken within one minute of exercise cessation. Following
the resistance exercise protocol, subjects remained in the
supine position for the full 30 min recovery phase prior to the
30P blood sample being drawn.
Blood samples were collected into two Vacutainer tubes,
one uncoated serum tube and one K2 EDTA plasma tube.
A small aliquot of whole blood was removed from the
K2 EDTA plasma tube and used for determination of hematocrit and hemoglobin. The blood in the serum tube was
allowed to clot at room temperature for 30 minutes and
subsequently centrifuged at 3,000 ×g for 15 minutes along
with the remaining whole blood from the K2 EDTA plasma
tube. The resulting plasma and serum were aliquoted into
separate 1.8 mL microcentrifuge tubes and frozen at −80∘ C
for later analysis.
2.6. Biochemical Analysis. Plasma HMB was analyzed by
Metabolic Technologies Inc. by gas chromatography-mass
spectrometry with previously outlined methods to confirm
HMB appearance in the plasma [22].
Plasma testosterone (cat. number: KGE010), serum
growth hormone (cat. number: DGH00), and plasma IGF1 (cat. number: DG100) were assayed via commercial kits
(R&D Systems Minneapolis, MN, USA). Serum insulin was
also assayed via a commercial kit (RayBiotech, Inc., Norcross,
GA, USA). Determination of serum immunoreactivity values
was determined using a BioTek Eon spectrophotometer
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Table 1: Characteristics of participants.

Age (years)
Height (m)
Weight (kg)
Body composition (% fat)
Squat 1-RM (kg)
Training experience (years)

HMB-FA
𝑛 = 10
21.7 ± 2.0
1.79 ± 0.08
81.1 ± 12.7
13.1 ± 4.8
135.9 ± 34.2
5.95 ± 2.5

Values are means ± SD.

(BioTek, Winooski, VT, USA). To eliminate interassay variance, all samples for a particular assay were thawed once and
analyzed in the same assay run by a single technician and
intra-assay variance for the hormones was 5.8%, 5.3%, 4.1%,
and 4.3% for testosterone, growth hormone, insulin, and IGF1, respectively.
2.7. Statistical Analysis. Prior to analysis, all data were
assessed to ensure normal distribution, homogeneity of variance, and sphericity. A 2 × 3 analysis of variance (ANOVA)
(group [PL, HMB-FA] × time [PRE, IP, 30P]) was used to
analyze all biochemical data. When appropriate, follow-up
analyses included one-way repeated measures ANOVAs and
LSD post hoc comparisons. In the event PRE values were
significantly different, an analysis of covariance (ANCOVA)
to analyze the effects of the intervention. The area under the
curve (AUC) for all hormone concentrations was calculated
by using a standard trapezoidal technique and was analyzed
using paired Student’s t-tests. An alpha level of 𝑃 < 0.05
was used to determine statistical significance. All data are
reported as mean ± SD. Data were analyzed using SPSS v22
software (SPSS Inc., Chicago, IL).

3. Results
The physical characteristics of the participants are presented
in Table 1. No significant differences were noted in any of
the anthropometric, strength, and experience level characteristics between groups. Plasma HMB concentrations were
significantly elevated at IP (𝑃 < 0.01; 137.4 ± 38.7 mmol/mL
versus 5.0 ± 5.8 mmol/mL) and 30P (𝑃 < 0.01; 153.0 ±
40.8 mmol/mL versus 5.0 ± 4.4 mmol/mL) for HMB-FA only
(Figure 1). In addition, the total training volume per exercise
session was not statistically different between groups. Plasma
HMB concentrations have been reported earlier [23].
3.1. Hormone Responses. Changes in testosterone concentrations can be seen in Figures 2(a) and 2(b). Significant
increases in testosterone were seen in both groups at IP
(𝑃 < 0.001) but returned to PRE concentrations by 30P
(𝑃 = 0.533). No between group differences were noted. AUC
analysis for plasma testosterone concentrations (Figure 2(b))
revealed no significant differences (𝑃 = 0.74) between the
groups.
Growth hormone concentrations were observed to
increase from PRE at IP (𝑃 < 0.001) and 30P (𝑃 < 0.001) in

Plasma HMB (mmol/mL)

Characteristics

Placebo
𝑛 = 10
23.8 ± 3.0
1.78 ± 0.03
85.7 ± 3.0
13.0 ± 3.0
148.0 ± 3.0
7.6 ± 3.0

∗#

160

∗#

140
120
100

∗

80
60
40
20
0

PRE

IP

30P
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HMB

Figure 1: Plasma HMB concentration values for PL, HMB-FA, and
time points at PRE, IP, and 30P. HMB was administered 15 min PRE
blood draw. ∗ Significantly elevated from PL and HMB-FA (𝑃 <
0.01); # significantly elevated from PRE (𝑃 < 0.01).

both groups in response to the exercise protocol (Figure 3(a)).
However, the elevation in HMB-FA was significantly higher
than PL at IP (𝑃 = 0.021), but no differences between the
groups were seen at 30P (𝑃 = 0.10). AUC analysis revealed a
significantly higher GH response (𝑃 = 0.02) in the HMB-FA
group compared to PL (see Figure 3(b)).
Changes in insulin concentrations can be observed in
Figures 4(a) and 4(b). Increases from PRE were observed in
both groups at IP (𝑃 = 0.008) and 30P (𝑃 = 0.015), but
no differences were observed between the groups. Figure 4(b)
depicts the AUC analysis on the insulin response during the
exercise protocol. No difference (𝑃 ≤ 0.92) was observed
between HMB-FA and PL.
Changes in IGF-1 concentrations from PRE to IP were
not statistically different (𝑃 = 0.69) but significantly
declined from IP to 30P (𝑃 = 0.015). IGF-1 values were
significantly different (𝑃 = 0.012) between the groups
at PRE. ANCOVA results showed no differences in IGF1 concentrations (𝑃 = 0.31) in response to the workout.
No differences were observed between the groups at IP or
30P (Figure 5(a)). However, AUC analysis (see Figure 5(b))
revealed a significant difference between HMB-FA and PL
(𝑃 = 0.02) with HMB-FA ingestion resulting in a greater
IGF-1 response following the resistance exercise protocol
compared to PL. There was a correlation trend between
plasma HMB AUC and IGF-1 AUC (𝑟2 = 0.585; 𝑃 = 0.089).

4. Discussion
The main findings of this investigation were that HMB-FA
ingestion prior to resistance exercise can augment both the
GH and IGF-1 response to a training session. To the best of
our knowledge, this is the first study to demonstrate acute
humoral alterations as a result of acute HMB-FA ingestion in
trained men. The results of this study also provide evidence
supporting a potentially greater anabolic response associated
with HMB supplementation [1, 7, 17].
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Figure 2: (a) Plasma testosterone concentration values for placebo (PL) and 𝛽-hydroxy-𝛽-methylbutyrate free acid (HMB-FA) groups before
exercise (PRE), immediately after exercise (IP), and 30 minutes after exercise (30P). ∗ Both groups significantly elevated from PRE (𝑃 ≤ 0.01).
(b) Area under the curve (AUC) analysis for plasma testosterone levels for PL and HMB-FA groups. Data were reported as mean ± SD.
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Figure 3: (a) Plasma growth hormone concentration values for placebo (PL) and 𝛽-hydroxy-𝛽-methylbutyrate free acid (HMB-FA) groups
before exercise (PRE), immediately after exercise (IP), and 30 minutes after exercise (30P). ∗ Both groups significantly elevated from PRE
(𝑃 ≤ 0.01). # HMB-FA significantly elevated from PL (𝑃 = 0.05). (b) Area under the curve (AUC) analysis for plasma growth hormone levels
for PL and HMB-FA groups. Data were reported as mean ± SD. ∗ Indicating HMB-FA group is significantly greater than PL.

There is a well-documented dose-response relationship
between training volume and the concomitant elevation
in growth hormone secretion [24–27]. The high volume
and short rest period employed during this study elicited
a significant elevation in the GH and IGF-1 response in
both treatment groups. Despite the similar training volumes
between groups, HMB-FA ingestion immediately preceding
the exercise protocol stimulated greater elevations in both
GH and IGF-1 concentrations compared to PL. Previous
studies have demonstrated that amino acids consumed
alone or in conjunction with exercise can stimulate GH
release to a greater magnitude when compared to placebo

ingestion [28–31]. Thus, HMB-FA may alter the GH/IGF-1
axis through similar pathways as its leucine progenitor. While
arginine, ornithine, and lysine [28–31] induce the largest
elevations in GH among the amino acids, leucine has also
been demonstrated to stimulate modest increases in GH
concentrations [32]. However, amino acid ingestion does not
appear to be as effective in enhancing the exercise-induced
elevations in GH concentrations [31, 33, 34]. Our findings
appear to be supported by a previous investigation examining
a murine model [19]. In that study, increases in pituitary
GH mRNA expression, hepatic IGF-1 expression, and serum
IGF-1 concentrations were observed following four weeks of
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Figure 4: (a) Serum insulin concentration values for placebo (PL) and 𝛽-hydroxy-𝛽-methylbutyrate free acid (HMB-FA) groups before
exercise (PRE), immediately after exercise (IP), and 30 minutes after exercise (30P). ∗ Both groups significantly elevated from PRE (𝑃 ≤ 0.01).
(b) Area under the curve (AUC) analysis for serum insulin levels for PL and HMB-FA groups. Data were reported as mean ± SD.
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Figure 5: (a) Plasma insulin-like growth factor (IGF-1) concentration values for placebo (PL) and 𝛽-hydroxy-𝛽-methylbutyrate free acid
(HMB-FA) groups before exercise (PRE), immediately after exercise (IP), and 30 minutes after exercise (30P). † Both groups significantly
lower than PRE values. (b) Area under the curve (AUC) analysis for plasma IGF-1 levels for PL and HMB-FA groups. Data were reported as
mean ± SD. ∗ Indicating HMB-FA group significantly greater than PL.

HMB supplementation [19]. Our results indicate that these
effects appear to occur following an acute ingestion as well.
Considering that one of the physiological roles of GH is to
stimulate lipolysis [35], the significantly greater GH response
in HMB-FA may provide further insight for the changes in
body composition observed in several studies examining the
efficacy of HMB [1, 2, 36].
The results of this study were unable to demonstrate
any effect of HMB ingestion on the insulin response to
the exercise protocol. This is in contrast with the study of
Gerlinger-Romero and colleagues [19] who reported significant increases in resting insulin concentrations in HMB

treated rats. These differences though are more likely a
function of the prolonged supplementation protocol used by
Gerlinger-Romero et al. [19], whereas we only investigated
the hormonal responses from an acute ingestion and training
session. While IGF-1 AUC values were significantly greater
in the HMB-FA group in our study, the HMB-FA group was
also elevated at baseline. Since the HMB-FA supplement was
administered 15 min before the PRE blood draw, it is possible
that HMB-FA is promoting IGF-1 secretion independently of
GH stimulation.
Our findings in regard to the effect of HMB and resistance
exercise on changes in the testosterone response suggest that
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acute ingestion does not augment the testosterone response
to exercise. This is consistent with other studies that have
examined the effects of prolonged supplementation of HMB
and were unable to see any effect either with the free acid
form [36] or as calcium salt [6]. Conversely, an amino acid
based supplement containing HMB produced higher resting
GH and testosterone levels following 12 weeks of resistance
training with no changes in insulin or IGF-1 [2]. Additionally, this study implemented three acute exercise protocols
throughout the 12 weeks to examine the acute response of
supplementation. At week 6 and week 9 of supplementation,
the testosterone response was elevated in the supplement
group, whereas GH, IGF-1, or insulin responses were similar
between the supplemental and control group. Thus, chronic
supplementation with HMB may result in a more pronounced
testosterone response, or it is possible that the other amino
acids in the supplement (taurine, arginine) contributed to the
observed hormonal response.
It is important to mention that the current investigation
only administered one gram of HMB-FA (30 min prior to
exercise) while other studies examining the effects of HMB
on markers of recovery and muscle protein balance/synthesis
have used three grams or chronic supplementation prior to
the exercise session [1, 17]. However, it seems that one gram
was sufficient in augmenting the transient exercise-induced
elevation in GH compared to the placebo group. Currently,
the literature is lacking in regard to the dose-response effects
of HMB and future research is needed to explore optimal
dosing strategies.
The rate of plasma HMB appearance we observed is in
agreement with other studies [8, 13] suggesting that HMB-FA
may be more beneficial than the calcium salt form when taken
immediately before exercise. However, a recent study found
no differences in absorption between HMB-FA and HMB-Ca
in the animal model when both forms were administered in
liquid suspension [37]. Thus, the gel form of HMB-FA may be
responsible for its observed salient features. It is important to
note that since we did not use HMB-Ca in the current study
for comparison, further investigations examining various
forms of HMB-FA and HMB-Ca are needed to translate
findings to a trained human population.
In summary, these results appear to be the first examination suggesting that one gram of HMB-FA can promote a
significantly greater postexercise increase in GH and IGF-1
compared to PL. This finding provides important contributions to our understanding of how HMB may affect endocrine
function in humans. It appears that the HMB may modify the
GH/IGF-1 axis while promoting no differences in circulating
testosterone levels.
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